Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solifenacin vs Levofloxacin vs Lornoxicam for Management of Intravesical BCG Side Effects
NCT03038321Phase 4Unknown
- Sponsor
- Mansoura University
- Start
- Feb 2017
- Primary completion
- Dec 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in Bacillus Calmette-Guérin cystitis comparing solifenacin, levofloxacin and lornoxicam (3 arms). Primary endpoint: Comparing the drugs efficacy on decreasing systemic and local side effects of BCG at 6 weeks. Status: unknown.
02
Drugs
solifenacinlevofloxacinlornoxicam
03
Conditions
Bacillus Calmette-Guérin cystitis
Beyond the preview
Go deeper on NCT03038321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03038321.